Twin Lakes Capital Management, LLC Crispr Therapeutics Ag Transaction History
Twin Lakes Capital Management, LLC
- $144 Million
- Q2 2024
A detailed history of Twin Lakes Capital Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Twin Lakes Capital Management, LLC holds 682 shares of CRSP stock, worth $34,618. This represents 0.02% of its overall portfolio holdings.
Number of Shares
682
Previous 682
-0.0%
Holding current value
$34,618
Previous $46,000
21.74%
% of portfolio
0.02%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding CRSP
# of Institutions
510Shares Held
57.4MCall Options Held
1.74MPut Options Held
1.84M-
Capital International Investors Los Angeles, CA7.87MShares$399 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$381 Million3.35% of portfolio
-
Nikko Asset Management Americas, Inc.3.15MShares$160 Million1.99% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$160 Million0.13% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$141 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.96B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....